SAN FRANCISCO--(BUSINESS WIRE)--Savonix, a global leader in digital tests for cognitive health, and Boston University School of Public Health, one of the nation’s leading schools of public health, announced today the launch of a landmark population health study in dementia.
The Alzheimer’s Disease Discovery Study (ASSIST) Study will digitally collect cognitive data, health history and lifestyle tracking data from 400,000 individuals. The study data will power first time knowledge of how lifestyle factors that increase dementia risk cluster to produce cognitive changes across an individual’s life space, to accelerate early intervention efforts and drug development in Alzheimer’s disease.
